Development
Zeo ScientifiX, Inc.
ZEOX
$1.96
-$0.01-0.51%
OTC PK
| 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 4.56M | 4.58M | 5.07M | 5.96M | 6.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.56M | 4.58M | 5.07M | 5.96M | 6.49M |
| Cost of Revenue | 507.60K | 643.90K | 690.30K | 708.60K | 753.40K |
| Gross Profit | 4.05M | 3.94M | 4.38M | 5.25M | 5.74M |
| SG&A Expenses | 10.71M | 12.65M | 14.41M | 14.63M | 14.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.22M | 13.30M | 15.10M | 15.34M | 15.33M |
| Operating Income | -6.66M | -8.72M | -10.03M | -9.38M | -8.84M |
| Income Before Tax | -6.99M | -9.04M | -10.15M | -9.62M | -9.02M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.99 | -9.04 | -10.15 | -9.62 | -9.02 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.99M | -8.92M | -10.02M | -9.49M | -8.90M |
| EBIT | -6.66M | -8.72M | -10.03M | -9.38M | -8.84M |
| EBITDA | -6.17M | -7.98M | -9.42M | -8.90M | -8.51M |
| EPS Basic | -0.98 | -1.30 | -1.57 | -1.57 | -1.56 |
| Normalized Basic EPS | -0.63 | -0.81 | -1.00 | -0.99 | -0.99 |
| EPS Diluted | -0.98 | -1.30 | -1.57 | -1.57 | -1.56 |
| Normalized Diluted EPS | -0.63 | -0.81 | -1.00 | -0.99 | -0.99 |
| Average Basic Shares Outstanding | 28.41M | 27.07M | 25.40M | 23.52M | 21.81M |
| Average Diluted Shares Outstanding | 28.41M | 27.07M | 25.40M | 23.52M | 21.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |